RYTM
Rhythm Pharmaceuticals Inc.

1,965
Mkt Cap
$7.25B
Volume
79,066.00
52W High
$113.91
52W Low
$45.91
PE Ratio
-36.15
RYTM Fundamentals
Price
$110.34
Prev Close
$109.12
Open
$109.36
50D MA
$101.16
Beta
1.11
Avg. Volume
668,943.76
EPS (Annual)
-$4.34
P/B
-585.66
Rev/Employee
$459,809.19
Loading...
Loading...
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
283

Frequently Asked Questions

What is Market Cap of Rhythm Pharmaceuticals Inc.?
What is the 52-week high for Rhythm Pharmaceuticals Inc.?
What is the 52-week low for Rhythm Pharmaceuticals Inc.?
What is Rhythm Pharmaceuticals Inc. stock price today?
What was Rhythm Pharmaceuticals Inc. stock price yesterday?
What is the PE ratio of Rhythm Pharmaceuticals Inc.?
What is the Price-to-Book ratio of Rhythm Pharmaceuticals Inc.?
What is the 50-day moving average of Rhythm Pharmaceuticals Inc.?
How many employess does Rhythm Pharmaceuticals Inc. has?

Latest RYTM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.